Alembic Pharmaceuticals is planning to the issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 350 crore on Private Placement Basis. The meeting of the NCD Committee of the company will be held on December 14, 2018, inter-alia to consider and approve the same.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.